833
Participants
Start Date
April 30, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Permixon® 160 mg
Oral administration - 160 mg twice daily.
Tamsulosine LP
Oral administration - 0.4 mg daily.
Placebo matching Permixon® 160 mg
Oral administration - twice daily.
Placebo matching Tamsulosine LP
Oral administration - daily.
Benešov
Litoměřice
Pilsen
Prague
Roudnice nad Labem
Sternberk
Ústí nad Labem
Angers
Créteil
Limoges
Lyon
Marseille
Montreuil-Juigné
Nice
Nieul-sur-Mer
Paris
Saint-Orens-de-Gameville
Seysses
Tiercé
Berlin
Hagenow
Halle
Hamburg
Herzogenaurach
Hettstedt
Leipzig
Markkleeberg
Michelstadt
Mülheim
Nuremberg
Regensburg
Bari
Catanzaro
Foggia
Messina
Milan
Napoli
Novara
Orbassano
Padua
Palermo
Pesaro
Pietra Ligure
Prato
Roma
Udine
Barcelona
Coslada
El Palmar Murcia
Figueres
Getafe
Madrid
Parla
Sabadell
Salamanca
San Sebastián de los Reyes
Seville
Utrera de la Encomienda
Pierre Fabre Medicament
INDUSTRY